PRESS RELEASE published on 06/07/2024 at 17:13, 1 year 1 month ago Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream bonyf NV reaffirms commitment to R&D and showcases proven efficacy of fast pain-relief mouth ulcer cream AphtoFix® through recent clinical study. Company focuses on advancing oral healthcare with innovative solutions R&D Clinical Study Bonyf NV Mouth Ulcer Cream Oral Healthcare
BRIEF published on 05/10/2024 at 15:10, 1 year 2 months ago Bonyf NV prévoit une croissance record en 2024 Prévisions De Ventes 2024 Bonyf SA Produits D'hygiène Bucco-dentaire Conformité MDR Fabrication Sous Contrat
BRIEF published on 05/10/2024 at 15:10, 1 year 2 months ago Bonyf NV Anticipates Record Breaking Growth in 2024 Bonyf NV 2024 Sales Forecast Oral Hygiene Products MDR Compliance Contract Manufacturing
PRESS RELEASE published on 05/10/2024 at 15:05, 1 year 2 months ago 2024 Sales Forecast: Unprecedented Growth on the Horizon bonyf NV (MLBON) expects unprecedented sales growth in 2024, leveraging compliance with European Medical Device Regulation and unique product offerings Sales Forecast Bonyf NV Oral Hygiene Products Unprecedented Growth European MDR
BRIEF published on 04/16/2024 at 15:24, 1 year 3 months ago Bonyf s'apprête à exposer au PLMA Amsterdam en mai 2024 Euronext Paris PLMA Amsterdam 2024 Bonyf NV Produits De Soins Bucco-dentaires Règlement Sur Les Dispositifs Médicaux
BRIEF published on 04/16/2024 at 15:24, 1 year 3 months ago Bonyf Set to Exhibit at PLMA Amsterdam in May 2024 Euronext Paris PLMA Amsterdam 2024 Bonyf NV Oral Care Products Medical Device Regulation
PRESS RELEASE published on 04/16/2024 at 15:19, 1 year 3 months ago bonyf exhibits at PLMA Amsterdam on 28-29 May 2024 bonyf NV, a Euronext Paris listed company specializing in oral comfort products, announces expansion of clientele due to successful PLMA Amsterdam exhibition participation. Company highlights products with patented formulations, proven clinical efficacy, and commercial presence in 37 countries Bonyf NV Oral Care Products Medical Device Regulation Oral Comfort PLMA Amsterdam
BRIEF published on 04/04/2024 at 18:22, 1 year 3 months ago Bonyf passe à la phase 2 du développement de sa crème fixatrice pour prothèses dentaires à base d'alginate organique Bonyf Crème Fixatrice Pour Prothèses Dentaires À Base D'alginate-organique Développement De La Phase 2 Innovation En Matière De Soins Bucco-dentaires Soins Des Prothèses Dentaires
BRIEF published on 04/04/2024 at 18:22, 1 year 3 months ago Bonyf Advances to Phase 2 in Development of its Alginate-Organic Denture Fixative Cream Bonyf Alginate-Organic Denture Fixative Cream Phase 2 Development Oral Care Innovation Denture Care
PRESS RELEASE published on 04/04/2024 at 18:17, 1 year 3 months ago bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream bonyf advances to Phase 2 in the development of Alginate-Organic Denture Fixative Cream, aiming for superior grip and comfort for denture wearers. Company strives for innovation and excellence in oral care Innovation Phase 2 Bonyf Alginate-Organic Denture Fixative Cream Oral Care
Published on 07/29/2025 at 00:30, 1 hour 50 minutes ago PPX Mining Announces Completion of Debt Settlements
Published on 07/29/2025 at 00:15, 2 hours 5 minutes ago Star Copper Announces Amended and Restated $4 Million LIFE Offering
Published on 07/28/2025 at 22:30, 3 hours 50 minutes ago Eagle Plains Announces Conditional Approval of Warrant Expiry Extension
Published on 07/28/2025 at 22:05, 4 hours 15 minutes ago Organto Foods Announces Appointment of Javier Reyes de la Campa as Co-Chair of the Board
Published on 07/28/2025 at 23:39, 2 hours 41 minutes ago EQS-Adhoc: PALFINGER AG: SUCCESSFUL PLACEMENT OF TREASURY SHARES
Published on 07/28/2025 at 22:21, 3 hours 59 minutes ago EQS-Adhoc: Mynaric expects the capital reduction to zero and subsequent capital increase to take effect shortly, resulting in the current shareholders to leave without compensation and trading to end
Published on 07/28/2025 at 22:15, 4 hours 5 minutes ago Abivax annonce la réalisation de son offre au public de 747,5 millions de dollars
Published on 07/28/2025 at 22:15, 4 hours 5 minutes ago Abivax Announces Closing of $747.5 Million Public Offering
Published on 07/28/2025 at 22:05, 4 hours 15 minutes ago Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
Published on 07/28/2025 at 17:50, 8 hours 30 minutes ago imerys-communiqué-28-juillet-2025-rachat-d-actions-du-21 au 25 juillet 2025
Published on 07/28/2025 at 17:40, 8 hours 39 minutes ago Reporting on share buyback transactions carried out between July 16 and July 22, 2025
Published on 07/28/2025 at 17:40, 8 hours 39 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 22 juillet 2025